FDAnews Announces — The Most Important Legal Cases Regulatory Affairs Specialists Absolutely Must Understand Webinar, Sept. 21, 2016

Share Article

From the First Amendment and off-label promotion to impossiblility preemption and drug design, legal cases have a direct impact on the jobs and daily responsibilities of regulatory affairs specialists. Join legal expert William Janssen, Professor of Law, Charleston Law School, on Sept. 21 when he’ll provide a practical explanation of recent key decisions that affect what regulatory affairs does every day.

The Most Important Legal Cases Regulatory Affairs Specialists
Absolutely Must Understand
**An FDAnews Webinar**
Sept. 21, 2016 — 1:30 p.m. – 3:00 p.m. ET
http://info.fdanews.com/the-most-important-legal-cases-pr        

From the First Amendment and off-label promotion to impossibility preemption and drug design, legal cases have a direct impact on the jobs and daily responsibilities of regulatory affairs specialists.

How has the RA role been affected by recent legal cases?

Join legal expert William Janssen — Professor of Law, Charleston Law School — on Sept. 21 when he’ll provide a practical explanation of recent key decisions that affect what regulatory affairs does every day. The cases covered include:

1. First Amendment and Off-Label Promotion
a. Amarin v. United States (S.D.N.Y. 2015)
b. Caronia v. United States (2d Cir. 2012)
c. Sorrell v. IMS Health (U.S. 2011)
2. Promotion, FDA, and FTC
a. POM Wonderful LLC v. FTC (D.C. Cir. 2015)
3. Prosecuting Executives
a. United States v. Quality Egg, LLC (N.D. Iowa 2015)
4. Bold Frontiers in Federal Preemption
a. Caplinger v. Medtronic, Inc. (10th Cir. 2015)
b. Incretin-Based Therapies Products Liability Litigation (S.D. Cal. 2015)
5. Impossibility Preemption & Drug Design
a. Yates v. Ortho-McNeil-Janssen Pharma (6th Cir. 2015)

After attending this webinar attendees will be able to:

  • Develop regulatory plans and programs that are compliant with significant critical recent court rulings
  • Better understand how the legal process impacts regulatory affairs
  • Collaborate more effectively with general counsel, in-house, and outside counsel in developing and implementing regulatory strategy
  • Discuss with authority the most important recent cases impacting the company from a regulatory perspective

Register today and learn from a legal expert how to develop regulatory strategies to comply with court decisions and existing rules and guidelines.

Meet the Presenter:
William Janssen, Professor of Law, Charleston School of Law
William M. Janssen joined the Charleston School of Law faculty in 2006 after a lengthy practice with the mid-Atlantic law firm of Saul Ewing LLP, where he was a litigation partner, a member of the firm’s seven-person governing executive committee, and chair of the interdisciplinary Life Sciences Practice Group. He concentrated his practice in pharmaceutical, medical device, and mass torts defense and risk containment.

Who Will Benefit:

  • Compliance officers
  • General/corporate counsel
  • Executive management
  • Quality assurance
  • Risk management specialists
  • Outside attorneys
  • Regulatory/legislative affairs professionals
  • Department supervisors/directors

Webinar Details:
The Most Important Legal Cases Regulatory Affairs Specialists
Absolutely Must Understand
Sept. 21, 2016 — 1:30 p.m. – 3:00 p.m. ET
http://info.fdanews.com/the-most-important-legal-cases-pr        

Tuition:
$287 per site

Easy Ways to Register:
Online: http://info.fdanews.com/the-most-important-legal-cases-pr                            
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website